Debatin KM - Search Results

1

Role of CD95-mediated adipocyte loss in autoimmune lipodystrophy.

Fischer-Posovszky P, Hebestreit H, Hofmann AK, Strauss G, Möller P, Debatin KM, Wabitsch M. Fischer-Posovszky P, et al. Among authors: debatin km. J Clin Endocrinol Metab. 2006 Mar;91(3):1129-35. doi: 10.1210/jc.2005-0737. Epub 2005 Dec 20. J Clin Endocrinol Metab. 2006. PMID: 16368755

2

APO-1 (CD95) mediated apoptosis in human T-ALL engrafted in SCID mice.

Lücking-Famira KM, Daniel PT, Möller P, Krammer PH, Debatin KM. Lücking-Famira KM, et al. Among authors: debatin km. Leukemia. 1994 Nov;8(11):1825-33. Leukemia. 1994. PMID: 7526086

3

APO-I-mediated apoptosis in normal and malignant lymphocytes.

Dhein J, Behrmann I, Daniel PT, Debatin KM, Klas C, Möller P, Oehm A, Trauth BC, Walczak H, Krammer PH. Dhein J, et al. Among authors: debatin km. Biochem Soc Trans. 1994 Aug;22(3):598-600. doi: 10.1042/bst0220598. Biochem Soc Trans. 1994. PMID: 7529730 Review. No abstract available.

4

Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, Schmidt A, Debatin KM, Krammer PH, Möller P. Leithäuser F, et al. Among authors: debatin km. Lab Invest. 1993 Oct;69(4):415-29. Lab Invest. 1993. PMID: 7693996

5

CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells.

Krammer PH, Galle PR, Möller P, Debatin KM. Krammer PH, et al. Among authors: debatin km. Adv Cancer Res. 1998;75:251-73. doi: 10.1016/s0065-230x(08)60744-7. Adv Cancer Res. 1998. PMID: 9709812 Review. No abstract available.

6

[The role of CD95 (APO-1/Fas) mutations in lymphoproliferative and malignant lymphatic diseases].

Beltinger C, Böhler T, Schrappe M, Ludwig WD, Debatin KM. Beltinger C, et al. Among authors: debatin km. Klin Padiatr. 1998 Jul-Aug;210(4):153-8. doi: 10.1055/s-2008-1043871. Klin Padiatr. 1998. PMID: 9743945 Review. German.

7

CD95 (APO-1/Fas) in hematopoietic diseases.

Debatin KM. Debatin KM. Results Probl Cell Differ. 1998;24:157-74. doi: 10.1007/978-3-540-69185-3_8. Results Probl Cell Differ. 1998. PMID: 9949836 Review. No abstract available.

8

Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells.

Fulda S, Strauss G, Meyer E, Debatin KM. Fulda S, et al. Among authors: debatin km. Blood. 2000 Jan 1;95(1):301-8. Blood. 2000. PMID: 10607716 Free article.

9

Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation.

Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, Heinze E, Debatin KM, Hauner H. Wabitsch M, et al. Among authors: debatin km. Int J Obes Relat Metab Disord. 2001 Jan;25(1):8-15. doi: 10.1038/sj.ijo.0801520. Int J Obes Relat Metab Disord. 2001. PMID: 11244452

10

IGF-I- and IGFBP-3-expression in cultured human preadipocytes and adipocytes.

Wabitsch M, Heinze E, Debatin KM, Blum WF. Wabitsch M, et al. Among authors: debatin km. Horm Metab Res. 2000 Nov-Dec;32(11-12):555-9. doi: 10.1055/s-2007-978685. Horm Metab Res. 2000. PMID: 11246824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters